Cervical Dysplasia and Colposcopy Denied by Insurance? How to Appeal

An abnormal Pap smear or positive HPV test can be frightening. Getting the follow-up care you need — colposcopy, biopsy, or LEEP — is medically essential. Yet insurance denials and unexpected billing for these services are a routine frustration for millions of women every year.

Here's how to understand why these denials happen and how to fight them.

The Preventive-to-Diagnostic Cost-Share Problem

This is the most widespread and misunderstood billing issue in women's preventive care. Here's how it works:

1. You go for your routine Pap smear — a USPSTF A-rated preventive service, covered at zero cost-share under the ACA.
2. Your Pap result comes back abnormal.
3. Your provider orders a colposcopy for further evaluation.
4. Your insurer now bills the colposcopy — and sometimes the original Pap visit — at your diagnostic cost-sharing rate, potentially hundreds of dollars.

Many patients believe this is illegal. The situation is actually nuanced: the ACA requires zero cost-sharing for the preventive screening itself. Follow-up diagnostic services — including colposcopy after an abnormal Pap — are a separate service that can be billed with cost-sharing under most plan interpretations.

However, some state laws go further. California, New York, and several other states have laws that require insurers to cover the entire preventive care visit — including follow-up services related to an abnormal preventive finding — at no cost-sharing. If you live in one of these states, the cost-sharing for your post-abnormal-Pap colposcopy may be unlawful.

Even in states without such laws, the original Pap smear visit should not be converted to a diagnostic billing code simply because an abnormality was found. The preventive status of the Pap visit should be preserved.

What Is Colposcopy and Why Is It Medically Necessary?

Colposcopy is a medical procedure that uses a magnifying instrument (colposcope) to closely examine the cervix after an abnormal Pap smear or positive high-risk HPV test. It is the standard diagnostic follow-up procedure per the American Society for Colposcopy and Cervical Pathology (ASCCP).

The ASCCP 2019 Risk-Based Management Consensus Guidelines provide a detailed decision-making framework. According to these guidelines, colposcopy is recommended for:

• Cervical cytology showing HSIL (high-grade squamous intraepithelial lesion)
• Cervical cytology showing ASC-H (atypical squamous cells cannot exclude HSIL)
• Cervical cytology showing AGC (atypical glandular cells)
• Positive high-risk HPV result combined with LSIL or ASCUS in certain situations
• Persistent ASCUS or LSIL after repeat testing

If your colposcopy was denied as "not medically necessary" after any of these findings, that denial directly contradicts ASCCP guidelines. Include the specific ASCCP recommendation in your appeal letter.

LEEP Procedure Prior Authorization Denied: How to Appeal" class="auto-link">Prior Authorization Denials

LEEP (loop electrosurgical excision procedure) is performed to remove areas of abnormal cervical tissue identified during colposcopy and biopsy. It is the standard treatment for CIN 2 (moderate cervical dysplasia) and CIN 3 (severe cervical dysplasia/carcinoma in situ).

Insurers routinely require prior authorization for LEEP and sometimes deny it, claiming:

• The procedure is "not medically necessary" despite biopsy-confirmed CIN 2 or CIN 3
• Watchful waiting should be attempted first (appropriate only in certain circumstances, not for CIN 3)
• The wrong CPT code was submitted

For CIN 3, ASCCP guidelines recommend treatment — not surveillance. Delaying LEEP for high-grade dysplasia creates a real risk of progression to cervical cancer. If your LEEP was denied for CIN 2 or CIN 3, your appeal should cite:

• Your biopsy pathology report showing the specific grade of dysplasia
• ASCCP 2019 guidelines stating that treatment is recommended for confirmed CIN 2/3
• The cancer progression risk of leaving CIN 3 untreated

Coding Issues: Getting the Billing Right

Colposcopy and LEEP are billed using specific CPT codes:

• Colposcopy without biopsy: CPT 57452
• Colposcopy with biopsy: CPT 57454 or 57455
• LEEP: CPT 57461 (with endocervical curettage) or 57460

Verify with your provider's billing department that the correct CPT code was submitted. Billing errors are a common cause of denials that can be resolved with a corrected claim.

How to Appeal a Colposcopy or LEEP Denial

Step 1: Get the denial letter with the specific reason code. Was it "not medically necessary," "prior auth required," or a cost-share dispute?

Step 2: Obtain your Pap smear and HPV results. Your appeal needs to show the specific abnormal finding that prompted the procedure.

Step 3: If biopsy was performed, include the pathology report. For LEEP appeals, the biopsy result showing CIN grade is critical.

Step 4: Cite ASCCP 2019 Risk-Based Management Guidelines. These guidelines are the definitive clinical authority for cervical dysplasia management.

Step 5: Check your state laws. If you're in a state with expanded preventive care cost-sharing protections, cite those laws in your appeal.

Step 6: File internally within 180 days, then escalate to External Independent Review: Complete Guide" class="auto-link">external review.

Fight Back With ClaimBack

ClaimBack helps you navigate the complex billing and medical necessity rules around cervical dysplasia care, generating an appeal letter that cites ASCCP guidelines and your state's specific protections.

Start your free appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs. External Insurance Appeal: What's the Difference?